Abstract
Radiation therapy of glioma is based on conventional imaging using computerized tomography (CT) and magnetic resonance imaging (MRI). However the results remain poor in part due to uncertainties in delineation of target volume and critical structures. Magnetic resonance spectroscopy imaging (MRSI) can provide additional information on metabolic activity in the selected region of brain tissue that may help in differentiating normal brain from tumor. The information that might be derived from MRSI to better delineate the optimal target volume for radiation therapy of gliomas will be discussed. Technical details of incorporating MRSI into radiation therapy treatment planning process will be presented.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bleehen NM, Stenning SP (1991) A medical research council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. Br J Cancer 64:769–774
Bottomley PA (1987) Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci 508:333–348
Byrne TN (1994) Imaging of gliomas. Semin Oncol 21:162–171
Chang J, Thakur SB, Huang W, Narayana A (2008) Magnetic resonance spectroscopy imaging (MRSI) and brain functional magnetic resonance imaging (fMRI) for radiotherapy treatment planning of glioma. Technol Cancer Res Treat 7:349–362
Chang J, Thakur S, Perera G, Kowalski A, Huang W, Karimi S, Hunt M, Koutcher J, Fuks Z, Amols H, Narayana A (2006) Image-fusion of MR spectroscopic images for treatment planning of gliomas. Med Phys 33:32–40
De Stefano N, Caramanos Z, Preul MC, Francis G, Antel JP, Arnold DL (1998) In vivo differentiation of astrocytic brain tumors and isolated demyelinating lesions of the type seen in multiple sclerosis using 1H magnetic resonance spectroscopic imaging. Ann Neurol 44:273–278
DiBiase SJ, Hosseinzadeh K, Gullapalli RP, Jacobs SC, Naslund MJ, Sklar GN, Alexander RB, Yu C (2002) Magnetic resonance spectroscopic imaging-guided brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 52:429–438
Duijn JH, Matson GB, Maudsley AA, Weiner MW (1992) 3D phase encoding 1H spectroscopic imaging of human brain. Magn Reson Imaging 10:315–319
Earnest IV F, Kelly PJ, Scheithauer BW, Kall BA, Cascino TL, Ehman RL, Forbes GS, Axley PL (1988) Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy. Radiology 166: 823–827
Fountas KN, Kapsalaki EZ, Vogel RL, Fezoulidis I, Robinson JS, Gotsis ED (2004) Noninvasive histologic grading of solid astrocytomas using proton magnetic resonance spectroscopy. Stereotact Funct Neurosurg 82:90–97
Graves EE, Pirzkall A, Nelson SJ, Larson D, Verhey L (2001) Registration of magnetic resonance spectroscopic imaging to computed tomography for radiotherapy treatment planning. Med Phys 28:2489–2496
Howe FA, Barton SJ, Cudlip SA, Stubbs M, Saunders DE, Murphy M, Wilkins P, Opstad KS, Doyle VL, McLean MA, Bell BA, Griffiths JR (2003) Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 49:223–232
Kaminogo M, Ishimaru H, Morikawa M, Ochi M, Ushijima R, Tani M, Matsuo Y, Kawakubo J, Shibata S (2001) Diagnostic potential of short echo time MR spectroscopy of gliomas with singlevoxel and point-resolved spatially localised proton spectroscopy of brain. Neuroradiology 43:353–363
Lee SW, Fraass BA, Marsh LH, Herbort K, Gebarski SS, Martel MK, Radany EH, Lichter AS, Sandler HM (1999) Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study. Int J Radiat Oncol Biol Phys 43:79–88
Li BSY, Babb JS, Soher BJ, Maudsley AA, Gonen O (2002) Reproducibility of 3D proton spectroscopy in the human brain. Magn Reson Med 47:439–446
MRC (Medical Research Council Brain Tumour Working Party). (2001) Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a medical research council trial. J Clin Oncol 19:509–518
McKnight TR, Lamborn KR, Love TD, Berger MS, Chang S, Dillon WP, Bollen A, Nelson SJ (2007) Correlation of magnetic resonance spectroscopic and growth characteristics within grades ii and iii gliomas. J Neurosurg 106: 660–666
McKnight TR, Noworolski SM, Vigneron DB, Nelson SJ (2001) An automated technique for the quantitative assessment of 3D-MRSI data from patients with glioma. J Magn Reson Imag 13:167–177
McKnight TR, Von dem Bussche MH, Vigneron DB, Lu Y, Berger MS, McDermott MW, Dillon WP, Graves EE, Pirzkall A, Nelson SJ (2002) Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. J Neurosurg 97:794–802
Moonen CT, von Kienlin M, van Zijl PC, Cohen J, Gillen J, Daly P, Wolf G (1989) Comparison of single-shot localization methods (steam and press) for in vivo proton NMR spectroscopy. NMR Biomed 2:201–208
Narayana A, Leibel SA (2002) Adult brain tumors. In: Leibel SA, Phillips TL (eds) Textbook of radiation oncology. Saunders, Philadelphia, PA, pp 463–495
Nelson DF, Diener-West M, Horton J, Chang CH, Schoenfeld CH, Nelson JS (1988) Combined modality approach to treatment of malignant gliomas – re-evaluation of rtog 7401/ecog 1374 with long-term follow-up: a joint study of the radiation therapy oncology group and the eastern cooperative oncology group. NCI Monogr 279–284
Nelson SJ, Graves E, Pirzkall A, Li X, Chan AA, Vigneron DB, McKnight TR (2002) In vivo molecular imaging for planning radiation therapy of gliomas: an application of 1H MRSI. J Magn Reson Imag 16:464–476
Park I, Tamai G, Lee MC, Chuang CF, Chang SM, Berger MS, Nelson SJ, Pirzkall A (2007) Patterns of recurrence analysis in newly diagnosed glioblastoma multiforme after three-dimensional conformal radiation therapy with respect to pre-radiation therapy magnetic resonance spectroscopic findings. Int J Radiat Oncol Biol Phys 69:381–389
Pirzkall A, McKnight TR, Graves EE, Carol MP, Sneed PK, Wara WW, Nelson SJ, Verhey LJ, Larson DA (2001) MR-spectroscopy guided target delineation for high-grade gliomas. Int J Radiat Oncol Biol Phys 50:915–928
Pirzkall A, Nelson SJ, McKnight TR, Takahashi MM, Li X, Graves EE, Verhey LJ, Wara WW, Larson DA, Sneed PK (2002) Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy. Int J Radiat Oncol Biol Phys 53:1254–1264
Shimizu H, Kumabe T, Tominaga T, Kayama T, Hara K, Ono Y, Sato K, Arai N, Fujiwara S, Yoshimoto T (1996) Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy. Am J Neuroradiol 17:737–747
Simmons A, Smail M, Moore E, Williams SCR (1998) Serial precision of metabolite peak area ratios and water referenced metabolite peak areas in proton MR spectroscopy of the human brain. Magn Reson Imag 16:319–330
Thornton AF Jr., Sandler HM, Ten Haken RK, McShan DL, Fraass BA, La Vigne ML, Yanke BR (1992) The clinical utility of magnetic resonance imaging in 3-dimensional treatment planning of brain neoplasms. Int J Rad Oncol Biol Phys 24:767–775
Wallner KE (1991) Radiation treatment planning for malignant astrocytomas. Semin Radiat Oncol 1:17–22
Wu X, Dibiase SJ, Gullapalli R, Yu CX (2004) Deformable image registration for the use of magnetic resonance spectroscopy in prostate treatment planning. Int J Radiat Oncol Biol Phys 58:1577–1583
Zaider M, Zelefsky MJ, Lee EK, Zakian KL, Amols HI, Dyke J, Cohen G, Hu YC, Endi AK, Chui CS, Koutcher JA (2000) Treatment planning for prostate implants using magnetic-resonance spectroscopy imaging. Int J Radiat Oncol Biol Phys 47:1085–1096
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Narayana, A., Chang, J. (2011). Use of Magnetic Resonance Spectroscopy Imaging (MRSI) in the Treatment Planning of Gliomas. In: Hayat, M. (eds) Tumors of the Central Nervous System, Volume 1. Tumors of the Central Nervous System, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-0344-5_39
Download citation
DOI: https://doi.org/10.1007/978-94-007-0344-5_39
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-0343-8
Online ISBN: 978-94-007-0344-5
eBook Packages: MedicineMedicine (R0)